Quick Takeaways
- David E. Lazar filed SCHEDULE 13D/A for Indaptus Therapeutics, Inc. Common Stock, $0.01 par value (INDP).
- Disclosed ownership: 48%.
- Date of event: 23 Mar 2026.
David E. Lazar - 23 Mar 2026 SCHEDULE 13D/A Report for Indaptus Therapeutics, Inc. Common Stock, $0.01 par value (INDP)
- Filing Manager
- David E. Lazar
- Reporting Manager
- Lazar David E.
- Symbol
- INDP
- Shares outstanding
- 4,306,280 shares
- Disclosed Ownership
- 2,064,000 shares
- Ownership
- 48%
- Form type
- SCHEDULE 13D/A
- Filing time
- 24 Mar 2026, 16:05:23 UTC
- Date of event
- 23 Mar 2026
- Previous filing
- 02 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"David E. Lazar disclosed 48% ownership in Indaptus Therapeutics, Inc. Common Stock, $0.01 par value (INDP) on 23 Mar 2026."
What Changed
- Previous schedule filing date: 02 Mar 2026.
- Current filing was accepted on 24 Mar 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lazar David E. | 48% | 2,064,000 | 2,064,000 | 0 | /s/ David E. Lazar | David E. Lazar | 0001932843 |